Drug
Hmpl 760 Planned Dose 1
Hmpl 760 Planned Dose 1: highest development phase Phase 2, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| HMPL-760 planned dose 1 NCT06601504 | Phase 2 | Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
Latest
No recent events.
Follow Hmpl 760 Planned Dose 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.